Policy and Advocacy
How NIH Funding Fuels Innovation and Economic Growth
Continued investment in the NIH is essential to fighting current and emerging health threats and to ensuring the U.S. remains a global leader in medical innovation.
Your Source for HIV Data
amfAR maintains a series of free interactive databases to inform policymakers, public health officials, advocates, researchers, and other stakeholders about key aspects of the evolving U.S. and global HIV epidemics. These essential resources provide comprehensive data on global HIV programming/funding, key populations, the opioid epidemic, COVID-19, and the U.S. Ending the Epidemic plan.
The Hidden Cost of Capping NIH Indirect Costs
Revision of federal grant policy for health research would deal economic blow to roughly 600 U.S. universities and university systems
Assessing the Impact of the PEPFAR Stop Work Order
A new analysis shows that the HIV funding freeze is reversing hard-won progress toward ending AIDS
Trump Order Requiring Suspension of PEPFAR HIV Services Will Place Lives at Risk
More than 20 million people living with HIV globally—including 550,000 children under 15— depend on daily services provided with support of the PEPFAR program